Seroprevalence of neutralizing antibodies to human adenovirus type 5 in healthy adults in China. (Q39581144)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22825819%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

title

Seroprevalence of neutralizing antibodies to human adenovirus type 5 in healthy adults in China (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22825819%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

0 references

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22825819%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

Bin Yu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22825819%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Yan Zhou

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22825819%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Hao Wu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22825819%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Yang Zhan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22825819%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Xiao Feng

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22825819%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Ranshen Geng

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22825819%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Yongge Wu

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22825819%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Wei Kong

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22825819%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Xianghui Yu

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22825819%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

publication date

1 September 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22825819%20AND%20SRC:MED&resulttype=core&format=json

Journal of Medical Virology

8 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22825819%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

volume

84

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22825819%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22825819%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

page(s)

1408-1414

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22825819%20AND%20SRC:MED&resulttype=core&format=json

Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D

8 February 2020

cites work

1 reference

Insufficient accumulation of viral late mRNAs restricts the replicative cycle of human adenovirus type 37 in A549 cells

21 January 2018

1 reference

Plasmid chemokines and colony-stimulating factors enhance the immunogenicity of DNA priming-viral vector boosting human immunodeficiency virus type 1 vaccines

21 January 2018

1 reference

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

21 January 2018

1 reference

Comparative Immunogenicity in Rhesus Monkeys of DNA Plasmid, Recombinant Vaccinia Virus, and Replication-Defective Adenovirus Vectors Expressing a Human Immunodeficiency Virus Type 1 gag Gene

21 January 2018

1 reference

Prevalence of serum neutralizing antibodies against chimpanzee adenovirus 63 and human adenovirus 5 in Kenyan children, in the context of vaccine vector efficacy

21 January 2018

1 reference

Safety and immunogenicity of adenovirus-vectored near-consensus HIV type 1 clade B gag vaccines in healthy adults

21 January 2018

1 reference

Baseline Ad5 serostatus does not predict Ad5 HIV vaccine-induced expansion of adenovirus-specific CD4+ T cells

21 January 2018

1 reference

Large epidemic of adenovirus type 4 infection among military trainees: epidemiological, clinical, and laboratory studies.

21 January 2018

1 reference

Identification of hexon-specific CD4 and CD8 T-cell epitopes for vaccine and immunotherapy

21 January 2018

1 reference

International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: Correlates of high Ad5 titers and implications for potential HIV vaccine trials

21 January 2018

1 reference

HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis

21 January 2018

1 reference

Epidemic spread of adenovirus type 4-associated acute respiratory disease between U.S. Army installations

21 January 2018

1 reference

Immunogenicity of recombinant fiber-chimeric adenovirus serotype 35 vector-based vaccines in mice and rhesus monkeys

21 January 2018

1 reference

Adenovirus-specific immunity after immunization with an Ad5 HIV-1 vaccine candidate in humans

21 January 2018

1 reference

HIV seroconversion without infection after receipt of adenovirus-vectored HIV type 1 vaccine

21 January 2018

1 reference

Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity

21 January 2018

1 reference

The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?

21 January 2018

1 reference

Quantifying Adenovirus-Neutralizing Antibodies by Luciferase Transgene Detection: Addressing Preexisting Immunity to Vaccine and Gene Therapy Vectors

21 January 2018

1 reference

Systemic and mucosal T-lymphocyte activation induced by recombinant adenovirus vaccines in rhesus monkeys

21 January 2018

1 reference

Epidemiology of adenovirus type 5 neutralizing antibodies in healthy people and AIDS patients in Guangzhou, southern China

21 January 2018

1 reference

Overcoming immunity to a viral vaccine by DNA priming before vector boosting

21 January 2018

1 reference

The influence of innate and pre-existing immunity on adenovirus therapy

21 January 2018

1 reference

Safety and Immunogenicity of a Replication‐Incompetent Adenovirus Type 5 HIV‐1 Clade Bgag/pol/nefVaccine in Healthy Adults

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JMV.23325

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22825819%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference